Clinical characteristics of Acinetobacter baumannii complex bacteremia in patients receiving total parenteral nutrition

被引:7
作者
Yin, Ti [1 ]
Chiang, Mei-Chun [2 ]
Liaw, Jen-Jiuan [3 ]
Kuo, Shu-Chen [2 ,4 ]
Chen, Te-Li [2 ,4 ,5 ]
Wang, Kai-Wei Katherine [1 ]
机构
[1] Natl Yang Ming Univ, Sch Nursing, Taipei 112, Taiwan
[2] Taipei Vet Gen Hosp, Div Infect Dis, Taipei, Taiwan
[3] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan
[4] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan
[5] Taipei Vet Gen Hosp, Immunol Res Ctr, Taipei, Taiwan
关键词
Acinetobacter baumannii; bacteremia; characteristics; outcome; total parenteral nutrition; MULTIDRUG-RESISTANT; RISK-FACTORS; INFECTIONS; IDENTIFICATION; OUTCOMES; SPACER;
D O I
10.1016/j.jcma.2011.12.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acinetobacter baumannii complex (Abc) comprises at least three phenotypically undifferentiated species, including A baumannii, Acinetobacter genomic species 3 (AGS 3) and Acinetobacter genomic species 13TU (AGS 13TU). Abc bacteremia had rarely been described in patients receiving total parenteral nutrition (TPN). in this study, we aimed to determine any differences in the clinical features of patients having TPN and bacteremia due to A baumannii and those due to nonbaumannii Abc (including AGS 3 and AGS 13TU). Methods: The data of patients who had received TPN and had Abc bacteremia in Taipei Veterans General Hospital between August 1998 and December 2007 were retrospectively reviewed. The Acinetobacter isolates were identified to genomic species level. Results: A total of 23 patients with A baumannii and 23 patients with nonbaumannii Abc (15 AGS 13TU and 8 AGS 3) bacteremia were identified. The two groups of the patients were comparable regarding their gender, age and APACHE II score at the onset of bacteremia. However, several clinical features were different between the two groups of the patients in the univariate analysis. Furthermore, A baumannii isolates were resistant to more classes of antibiotics than nonbaumannii Abc isolates. The multivariate analysis showed that a higher number of patients with A baumannii bacteremia had received TPN for >= 15 days before their onset of bacteremia [odds ratio (OR) 7.214, 95% confidence interval (CI) (1.108-46.989), p = 0.039]. Nevertheless, the 14-day (30.4% vs. 21.7%, p = 0.737) and all-cause in-hospital mortality rate (60.9% vs. 39.1%, p = 0.238) did not differ significantly between these two groups. Conclusion: The patients with A baumannii bacteremia demonstrated a longer timeframe in the treatment of TPN prior to the onset of bacteremia than those with nonbaumannii Abc bacteremia, however the clinical outcomes between the two groups of the patients did not differ significantly. Copyright (C) 2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 50 条
  • [21] Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia
    Park, Se Yoon
    Choo, Jin Woo
    Kwon, Soon Ha
    Yu, Shi Nae
    Lee, Eun Jung
    Kim, Tae Hyong
    Choo, Eun Ju
    Jeon, Min Huok
    INFECTION AND CHEMOTHERAPY, 2013, 45 (03) : 325 - 330
  • [22] Acinetobacter baumannii bacteremia:: Clinical and prognostic features
    Rodríguez-Baño, J
    Pascual, A
    Gálvez, J
    Muniain, MA
    Ríos, MJ
    Martínez-Martínez, L
    Pérez-Cano, R
    Perea, EJ
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (05): : 242 - 247
  • [23] Comparative Analysis of Clinical Characteristics and Antimicrobial Resistance Between Acinetobacter baumannii and Other Acinetobacter Species
    Kim, Si-Ho
    Mun, Seok Jun
    PATHOGENS, 2025, 14 (01):
  • [24] Evaluation of outcomes for patients with AIDS receiving home total parenteral nutrition
    Ireton-Jones, CS
    Stiller, DL
    NUTRITION, 1998, 14 (09) : 731 - 735
  • [25] Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia
    Chiang, Tsung-Ta
    Huang, Tzu-Wen
    Sun, Jun-Ren
    Kuo, Shu-Chen
    Cheng, Aristine
    Liu, Chang-Pan
    Liu, Yuag-Meng
    Yang, Ya-Sung
    Chen, Te-Li
    Lee, Yi-Tzu
    Wang, Yung-Chih
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [26] Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant acinetobacter baumannii
    Gulen, Tugba Arslan
    Guner, Rahmet
    Celikbilek, Nevreste
    Keske, Siran
    Tasyaran, Mehmet
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 38 : 32 - 35
  • [27] Comparison of clinical manifestations and antibiotic resistances among three genospecies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex
    Chen, Lu
    Yuan, Juxiang
    Xu, Yingjun
    Zhang, Fengxia
    Chen, Zhenlei
    PLOS ONE, 2018, 13 (02):
  • [28] Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia
    Lee, Yi-Tzu
    Chiang, Mei-Chun
    Kuo, Shu-Chen
    Wang, Yung-Chih
    Lee, I-Hsin
    Chen, Te-Li
    Yang, Ya-Sung
    PLOS ONE, 2016, 11 (09):
  • [29] Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED
    Kang, Cheol-In
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Song, Jae-Hoon
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2012, 30 (07) : 1169 - 1175
  • [30] Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
    Papathanakos, Georgios
    Andrianopoulos, Ioannis
    Papathanasiou, Athanasios
    Priavali, Efthalia
    Koulenti, Despoina
    Koulouras, Vasilios
    MICROORGANISMS, 2020, 8 (02)